Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Poseida Therapeutics gets FDA orphan drug designation for P-BCMA-ALLO1 in multiple myeloma Poseida Therapeutics, Inc. (Nasdaq: PSTX), a trailblazer in the field of clinical-stage cell and gene therapy, has achieved… byPallavi MadhirajuMarch 14, 2024